These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 13777925)

  • 1. [Spectrophotometric determination of kallikrein and its inactivators].
    TRAUTSCHOLD I; WERLE E
    Hoppe Seylers Z Physiol Chem; 1961 Jun; 325():48-59. PubMed ID: 13777925
    [No Abstract]   [Full Text] [Related]  

  • 2. [Research on the inhibitory property of the blood toward trypsin and its control by intravenous administration of kallikrein and trypsin gland inactivators].
    FORELL MM; DOBOVICNIK W
    Blut; 1961 Jul; 7():136-42. PubMed ID: 13894034
    [No Abstract]   [Full Text] [Related]  

  • 3. Natural and engineered kallikrein inhibitors: an emerging pharmacopoeia.
    Swedberg JE; de Veer SJ; Harris JM
    Biol Chem; 2010 Apr; 391(4):357-74. PubMed ID: 20180638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Attempts at the isolation of the kallikrein inactivator. III. Electrophoretic purification and molecular weight determination in the ultracentrifuge].
    KRAUT H; KOERBEL W; SCHOLTAN W; SCHULTZ F
    Hoppe Seylers Z Physiol Chem; 1960 Dec; 321():90-6. PubMed ID: 13754125
    [No Abstract]   [Full Text] [Related]  

  • 5. Current status of tissue kallikrein inhibitors: importance in cancer.
    Bhoola KD; Misso NL; Naran A; Thompson PJ
    Curr Opin Investig Drugs; 2007 Jun; 8(6):462-8. PubMed ID: 17621876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of human tissue kallikrein by alpha 1-proteinase inhibitor.
    Hirano K; Okumura Y; Hayakawa S; Adachi T; Sugiura M
    Hoppe Seylers Z Physiol Chem; 1984 Jan; 365(1):27-32. PubMed ID: 6201429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 1,2,4-Triazole derivatives as transient inactivators of kallikreins involved in skin diseases.
    Tan X; Furio L; Reboud-Ravaux M; Villoutreix BO; Hovnanian A; El Amri C
    Bioorg Med Chem Lett; 2013 Aug; 23(16):4547-51. PubMed ID: 23849879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Differentiation between kallikrein and kallikrein elements by means of antiserum and diisopropylfluorophosphate].
    HABERMANN E
    Hoppe Seylers Z Physiol Chem; 1962 Jun; 328():24-30. PubMed ID: 13903391
    [No Abstract]   [Full Text] [Related]  

  • 9. Inhibitors of kallikrein-related peptidases: An overview.
    Masurier N; Arama DP; El Amri C; Lisowski V
    Med Res Rev; 2018 Mar; 38(2):655-683. PubMed ID: 28609548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Separation and purification of pancreatic kallikrein].
    HABERMANN E
    Hoppe Seylers Z Physiol Chem; 1962 Jun; 328():15-23. PubMed ID: 13903392
    [No Abstract]   [Full Text] [Related]  

  • 11. Pyrido-imidazodiazepinones as a new class of reversible inhibitors of human kallikrein 7.
    Arama DP; Soualmia F; Lisowski V; Longevial JF; Bosc E; Maillard LT; Martinez J; Masurier N; El Amri C
    Eur J Med Chem; 2015 Mar; 93():202-13. PubMed ID: 25682203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crystal structure of human epidermal kallikrein 7 (hK7) synthesized directly in its native state in E. coli: insights into the atomic basis of its inhibition by LEKTI domain 6 (LD6).
    Fernández IS; Ständker L; Mägert HJ; Forssmann WG; Giménez-Gallego G; Romero A
    J Mol Biol; 2008 Apr; 377(5):1488-97. PubMed ID: 18329042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-based drug design of 1,3,6-trisubstituted 1,4-diazepan-7-ones as selective human kallikrein 7 inhibitors.
    Murafuji H; Sakai H; Goto M; Oyama Y; Imajo S; Sugawara H; Tomoo T; Muto T
    Bioorg Med Chem Lett; 2018 May; 28(8):1371-1375. PubMed ID: 29550094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [On an antagonist for kallikrein and various proteinases from cattle liver. III].
    APPEL W; WERLE E
    Z Naturforsch B; 1959 Oct; 14B():648-54. PubMed ID: 13848828
    [No Abstract]   [Full Text] [Related]  

  • 15. Development of plasma kallikrein selective inhibitors.
    Okada Y; Tsuda Y; Tada M; Wanaka K; Hijikata-Okunomiya A; Okamoto U; Okamoto S
    Biopolymers; 1999; 51(1):41-50. PubMed ID: 10380351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kallikreins on steroids: structure, function, and hormonal regulation of prostate-specific antigen and the extended kallikrein locus.
    Lawrence MG; Lai J; Clements JA
    Endocr Rev; 2010 Aug; 31(4):407-46. PubMed ID: 20103546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of the kallikrein-kinin system in sheep and dogs.
    GADDUM JH; GUTH PS
    Br J Pharmacol Chemother; 1960 Mar; 15(1):181-4. PubMed ID: 13825852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tissue kallikrein-like immunoreactive material decorates neuritic plaques of Alzheimer patients.
    Bernstein HG
    Clin Neuropathol; 1997; 16(2):69-71. PubMed ID: 9101107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of a new kallikrein-like enzyme (KLP-S3) of the rat submandibular gland.
    Berg T; Schøyen H; Wassdal I; Hull R; Gerskowitch VP; Toft K
    Biochem J; 1992 Feb; 281 ( Pt 3)(Pt 3):819-28. PubMed ID: 1536657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The inhibition of porcine pancreas kallikrein by di-isopropyl-fluorophosphate. Kinetics, stoichiometry, and nature of the group phosphorylated.
    Fiedler F; Müller B; Werle E
    Eur J Biochem; 1969 Oct; 10(3):419-25. PubMed ID: 5388498
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.